Skip to main content

Advertisement

Log in

Serum leptin in rheumatoid arthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Leptin is a peptide hormone that has an essential role in the regulation of body weight by inhibiting food intake and stimulating energy expenditure. The role of leptin in the modulation of the immune response and inflammation has been regarded as important. In rheumatoid arthritis (RA) patients it was reported that fasting leads to an improvement of clinical and biological measures of disease activity, which was associated with a marked decrease in serum leptin. These features suggest that leptin may also influence the inflammatory mechanisms of arthritis in humans. In this study we assessed serum leptin levels in RA and osteoarthritis (OA) patients and found a correlation between serum leptin level and other markers as well as bone mass density changes, activity of disease, disease duration and the age of the patients. The blood was collected from 30 RA and 30 OA patients who constituted the control group. Serum leptin level was determined using the DRG Leptin ELISA Kit—a solid phase enzyme—linked immunosorbent assay based on the sandwich principle. The serum level of leptin in RA patients ranged from 1.8 to 81.1 ng/ml and median value was 11.2. There was a positive correlation between body mass index (BMI) of RA patients and serum level of leptin (correlation coefficients Spearman’s r = 0.81). According to correlation coefficients, serum leptin level is independent of age of RA patients, stage of disease, number of painful and swollen joints, duration of morning stiffness, disease duration as well as value of titre of the Waaler–Rose, disease activity score (DAS 28) value and presence of rheumatoid nodules. There was a negative correlation between serum leptin level and glomerular filtration rate (GFR). No correlation between the serum leptin level and T-score was found. An influence of steroid treatment on the serum leptin level was not shown. The median serum leptin level in OA patients was 9.2 ng/ml. There was a positive correlation between body mass index of OA patients and serum level of leptin (correlation coefficients Spearman’s r = 0.57). No correlation was found between serum leptin level and patient’s age, duration of disease and value of laboratory data. There were no correlations between serum leptin level and visual analogue pain scale (VAS) for the lower-limb afflicted patients as well as stage of disease according to Kellgren and Lawrence’s score in OA patients. There was a negative correlation between serum leptin level and T-score value in OA patients (r = −0.58, P < 0.05). No statistically significant differences were found between serum leptin levels for RA and OA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413–437

    Article  PubMed  CAS  Google Scholar 

  2. Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and, hematopoiesis. J Leukoc Biol 68:437–446

    PubMed  CAS  Google Scholar 

  3. Lord GM, Matarese G, Howard JK et al (1998) Leptin modulates the T-cell immune response and reserves starvation-induced immunosuppression. Nature 394:897–901

    Article  PubMed  CAS  Google Scholar 

  4. Busso N, So A, Chobaz-Peclat V et al (2002) Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 169:875–872

    Google Scholar 

  5. Howard JK, Lor GM, Matarese G et al (1999) Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob./ob. mice. J Clin Invest 104:1051–1059

    PubMed  CAS  Google Scholar 

  6. Flier JS (1998) Lowered leptin slims immune response. Nat Med 4:1124–1125

    Article  PubMed  CAS  Google Scholar 

  7. Farooqi IS, Matarese G, Lord GM et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093–1103

    Article  PubMed  CAS  Google Scholar 

  8. Saraf P, Fantuzzi G, Fuler J et al (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185:171–175

    Article  Google Scholar 

  9. Faggioni R, Fantuzzi G, Fuler J et al (1998) Il-1 beta mediates leptin induction during inflammation. Am J Physiol 274:R 204–208

    Google Scholar 

  10. Loffreda S, Yang SQ, Lin HZ et al (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:577–65

    Google Scholar 

  11. Gabay C, Dreyer M, Pellegrineli N et al (2001) Leptin directly induces the secretion of interleulin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86:783–791

    Article  PubMed  CAS  Google Scholar 

  12. Takahashi N, Waelput W, Guisez Y (1999) Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 189:207–212

    Article  PubMed  CAS  Google Scholar 

  13. Fraser DA, Thoen J, Reseland JE et al (1999) Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18:394–401

    Article  PubMed  CAS  Google Scholar 

  14. Arnett FC (1989) Revised criteria for the classification of rheumatoid arthritis. Bul Rheum Dis 38:1–6

    CAS  Google Scholar 

  15. Steinbrocker O, Treger H, Cornelius H (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662

    CAS  Google Scholar 

  16. Larsen A, Dale K, Eek M (1977) Radiographic eveluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 18:481–491

    CAS  Google Scholar 

  17. Van der Heijde DMFM, van’t Hof MA, van Riel PLCM et al (1993) Development of a disease activity score based on judgement in clinical practice by rheumatologists. J Rheumatol 20:579–581

    PubMed  Google Scholar 

  18. Altman R (1991) Classification of disease:osteoarthritis. Semin Arthritis Rheum 21(Suppl 2):40–47

    Article  Google Scholar 

  19. Bellamy N, Buchanan WW, Goldsmith CH, et al (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840

    PubMed  CAS  Google Scholar 

  20. Kellgren JH, Lawrence SJ (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502

    PubMed  CAS  Google Scholar 

  21. Conside RV, Sinha MK, Heiman ML (1996) Serum immunoreactive—leptin concentrations in normal weight and obese humans. New Engl J Med 334:292–295

    Article  Google Scholar 

  22. Robert R, Sokal F, Rohlf J (1986) Biometry. Freeman, New York, pp 354–359, 691–714

  23. Gainsford T, Willson TA, Metcalf D et al (1996) Leptin can induce proliferation, differentiation and functional activation of hemopoeitic cells. Proc Natl Acad Sci USA 93:14564–14568

    Article  PubMed  CAS  Google Scholar 

  24. Charles P, Elliott MJ, Davis D (1999) Regulation of cytokines, cytokine inhibitors and acute-phase proteins folowing anti-TNF alpha therapy in rheumatoid arthritis. J Immunol 163:1521–1528

    PubMed  CAS  Google Scholar 

  25. Roubenoff R, Roubenoff RA, Ward LM et al (1994) Rheumatoid cachexia; cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 93:2379–2389

    Article  PubMed  CAS  Google Scholar 

  26. Sarraf P, Frederich RC, Turner EM (1997) Multiple cytokines and acute inflammation raise mouse leptin levels. Potential role in inflammatory anorexia. J Exp Med 185:171–175

    Article  PubMed  CAS  Google Scholar 

  27. Anders HJ, Rihl M, Heufelder A et al (1999) Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism 48:745–748

    Article  PubMed  CAS  Google Scholar 

  28. Nishiya K, Nishiiyama M, Chang A et al (2002) Serum leptin in patients with rheumatoid arthritis are correlated with body mass index. Abstract Rinshobyori 50:524–527

    Google Scholar 

  29. Tokarczuk-Knapik A, Nowicki M, Wyroslak J (2002) The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis. Pol Arch Med Wewn 108:761–767

    Google Scholar 

  30. Bokarewa M, Bokarew D, Hultgren O et al (2003) Leptin consumption in the inflammed joits of patients with rheumatoid arthritis. Ann Rheum Dis 62:952–956

    Article  PubMed  CAS  Google Scholar 

  31. Dumond H, Presle N, Terlain B (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 11:3118–3129

    Article  CAS  Google Scholar 

  32. Rubin CT, Lanyon LE (1985) Regulation of bone mass by mechanical strain magnitude. Calcif Tissue Int 37:411–417

    Article  PubMed  CAS  Google Scholar 

  33. Albala C, Yanez M, Devoto E et al (1996) Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes 20:1027–1032

    CAS  Google Scholar 

  34. Reid IR, Ames R, Evans M et al (1992) Determinants of total body and regional bone mineral density in normal postmenopausal women—a key role for fat mass. J Clin Endocrinol Metab 75:45–51

    Article  PubMed  CAS  Google Scholar 

  35. Bai Y, Zhang S, Kim LS et al (1996) Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 271:13939–13942

    Article  PubMed  CAS  Google Scholar 

  36. Aubin JE, Turksen K, Heershe JNM (1993) Osteoblastic cell linkage (w) Celular and molecular biology of bone, (red) M. Noda, Academic Press, New York, pp 1–45

  37. Thomas T, Gori F, Khosla S et al (1999) Leptin acts on human marrow stromal cels to enhance differentiation to osteoblast and to inhibit differentiation to adipocytes. Endocrinology 140:1630–1638

    Article  PubMed  CAS  Google Scholar 

  38. Ducy P, Amling M, Taskeda S et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207

    Article  PubMed  CAS  Google Scholar 

  39. Matkovic V, Ilich J, Skugor M et al (1997) Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 82:3239–3245

    Article  PubMed  CAS  Google Scholar 

  40. Gulding A, Taylor RW (1998) Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 63:456–458

    Article  Google Scholar 

  41. Odabasi E, Ozata M, Turan M et al (2000) Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170–173

    Article  PubMed  CAS  Google Scholar 

  42. Rauch F, Blum WF, Klein K et al (1998) Does leptin have an effect on bone in adult women? Calcif Tissue Int 63:453–455

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Margaret Wisłowska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wisłowska, M., Rok, M., Jaszczyk, B. et al. Serum leptin in rheumatoid arthritis. Rheumatol Int 27, 947–954 (2007). https://doi.org/10.1007/s00296-007-0335-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-007-0335-4

Keywords

Navigation